These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32008389)

  • 21. Role of Ketamine in Severe Depression with suicidal ideation - Insights from a Case Study.
    Gurnani T; Khurshid KA
    Asian J Psychiatr; 2017 Oct; 29():112-113. PubMed ID: 29061405
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment-refractory depression: a case of successful treatment with intranasal ketamine 10%.
    Clark P
    Ann Clin Psychiatry; 2014 May; 26(2):145. PubMed ID: 24501735
    [No Abstract]   [Full Text] [Related]  

  • 23. A word to the wise about ketamine.
    Schatzberg AF
    Am J Psychiatry; 2014 Mar; 171(3):262-4. PubMed ID: 24585328
    [No Abstract]   [Full Text] [Related]  

  • 24. Ketamine for treatment-resistant depression: ready or not for clinical use?
    Rush AJ
    Am J Psychiatry; 2013 Oct; 170(10):1079-81. PubMed ID: 23982324
    [No Abstract]   [Full Text] [Related]  

  • 25. Electroconvulsive therapy is a standard treatment; ketamine is not (yet).
    Kellner CH; Greenberg RM; Ahle GM; Liebman LS
    Am J Psychiatry; 2014 Jul; 171(7):796. PubMed ID: 24980176
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterizing the course of suicidal ideation response to ketamine.
    Ballard ED; Yarrington JS; Farmer CA; Richards E; Machado-Vieira R; Kadriu B; Niciu MJ; Yuan P; Park L; Zarate CA
    J Affect Disord; 2018 Dec; 241():86-93. PubMed ID: 30099268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increase in PAS-induced neuroplasticity after a treatment course of intranasal ketamine for depression. Report of three cases from a placebo-controlled trial.
    Gálvez V; Nikolin S; Ho KA; Alonzo A; Somogyi AA; Loo CK
    Compr Psychiatry; 2017 Feb; 73():31-34. PubMed ID: 27886522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Riluzole likely lacks antidepressant efficacy in ketamine non-responders.
    Niciu MJ; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Furey ML; Zarate CA
    J Psychiatr Res; 2014 Nov; 58():197-9. PubMed ID: 25139008
    [No Abstract]   [Full Text] [Related]  

  • 29. Continuation phase intravenous ketamine in adults with treatment-resistant depression.
    Vande Voort JL; Morgan RJ; Kung S; Rasmussen KG; Rico J; Palmer BA; Schak KM; Tye SJ; Ritter MJ; Frye MA; Bobo WV
    J Affect Disord; 2016 Dec; 206():300-304. PubMed ID: 27656788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neural correlates of suicidal ideation and its reduction in depression.
    Ballard ED; Lally N; Nugent AC; Furey ML; Luckenbaugh DA; Zarate CA
    Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25550331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment-Resistant Depression and Ketamine Response in a Patient With Bilateral Amygdala Damage.
    Scheele D; Zimbal S; Feinstein JS; Delis A; Neumann C; Mielacher C; Philipsen A; Hurlemann R
    Am J Psychiatry; 2019 Dec; 176(12):982-986. PubMed ID: 31787017
    [No Abstract]   [Full Text] [Related]  

  • 32. Ameliorating treatment-refractory depression with intranasal ketamine: potential NMDA receptor actions in the pain circuitry representing mental anguish.
    Opler LA; Opler MG; Arnsten AF
    CNS Spectr; 2016 Feb; 21(1):12-22. PubMed ID: 25619798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of suicidal depression with ketamine in rapid cycling bipolar disorder.
    Sampath H; Sharma I; Dutta S
    Asia Pac Psychiatry; 2016 Mar; 8(1):98-101. PubMed ID: 26871425
    [No Abstract]   [Full Text] [Related]  

  • 34. Ketamine as a potential treatment for suicidal ideation: a systematic review of the literature.
    Reinstatler L; Youssef NA
    Drugs R D; 2015 Mar; 15(1):37-43. PubMed ID: 25773961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal ketamine treatment in an adult with autism spectrum disorder.
    Wink LK; O'Melia AM; Shaffer RC; Pedapati E; Friedmann K; Schaefer T; Erickson CA
    J Clin Psychiatry; 2014 Aug; 75(8):835-6. PubMed ID: 25191906
    [No Abstract]   [Full Text] [Related]  

  • 36. Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior.
    Mallick F; McCullumsmith CB
    Curr Psychiatry Rep; 2016 Jun; 18(6):61. PubMed ID: 27194043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Considerations for use of ketamine to treat depression in Australia and New Zealand.
    Bayes A; Dong V; Loo C
    Aust N Z J Psychiatry; 2019 Nov; 53(11):1117-1120. PubMed ID: 31364369
    [No Abstract]   [Full Text] [Related]  

  • 38. Ketamine as an alternative treatment for treatment-resistant depression.
    Dowben JS; Grant JS; Keltner NL
    Perspect Psychiatr Care; 2013 Jan; 49(1):2-4. PubMed ID: 23293991
    [No Abstract]   [Full Text] [Related]  

  • 39. Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study.
    Domany Y; Bleich-Cohen M; Tarrasch R; Meidan R; Litvak-Lazar O; Stoppleman N; Schreiber S; Bloch M; Hendler T; Sharon H
    Br J Psychiatry; 2019 Jan; 214(1):20-26. PubMed ID: 30246667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.
    Phillips JL; Norris S; Talbot J; Birmingham M; Hatchard T; Ortiz A; Owoeye O; Batten LA; Blier P
    Am J Psychiatry; 2019 May; 176(5):401-409. PubMed ID: 30922101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.